The courtroom fell silent as Judge Colleen McMahon announced a stunning $949 million penalty against Omnicare for years of false claims to federal health programs. Lawyers exchanged uneasy glances as the judge called it “very big fraud.” The verdict marked the start of a crisis that would push the pharmacy giant toward bankruptcy.
But Omnicare’s troubles were only beginning.
Whistleblower Lawsuit Filed
In 2015, a former Omnicare pharmacist named Uri Bassan filed a whistleblower lawsuit. He accused Omnicare of illegally billing government insurance for prescriptions that were invalid.
In 2019, the U.S. Justice Department joined the case. Investigators said Omnicare billed Medicare, Medicaid, and military health programs for drugs given to long-term care patients without proper prescriptions.
Fraud Allegations
Investigators said Omnicare sent drugs to nursing home residents using “stale, invalid prescriptions”. They claimed the company then billed Medicaid and Medicare for those drugs even though the prescriptions had expired or were out of refills.
These charges were alleged to have happened from 2010 through 2018. Omnicare and CVS denied the claims, calling them without merit.
Court Trial and Verdict
U.S. District Judge Colleen McMahon in Manhattan oversaw the case. In April 2025, a jury found Omnicare’s actions caused $135.6 million in losses.
By law, Judge McMahon tripled that amount to $406.8 million and added $542.0 million in penalties. All told, she held Omnicare (and part of CVS) responsible for almost $949 million.
A Near-$1B Judgment
In July 2025, Judge McMahon formally ordered Omnicare to pay about $948.8 million. This huge ruling is the central of the story. Omnicare’s president, David Azzolina, called the penalty “extreme and … unconstitutional”.
The decision meant Omnicare faced nearly a billion dollars in debt. CVS Health announced it would appeal the verdict.
Omnicare and CVS Respond
After the verdict, CVS said it would appeal. Omnicare noted that the lawsuit never claimed any patient was harmed.
The company warned that the ruling could hurt its ability to serve customers, so it began looking at options like restructuring. By late August 2025, Omnicare reported having up to $10 billion in debt and $500 million in assets.
Financial Strain and Financing
By mid-August 2025, Omnicare had arranged $110 million in financing to continue operations during the court process. CVS said it had been exploring “strategic options” for Omnicare as losses mounted.
Omnicare said it would keep serving nursing home customers without interruption. This financing was debtor-in-possession funding to pay wages, benefits, and vendors while the company reorganized.
False Claims Act Explained
Federal law (the False Claims Act) lets courts impose triple damages for fraud on government programs. That is why the jury’s $135.6 million loss became $406.8 million in damages.
The law required the judge to triple the award and add penalties. Under this rule, fraud cases can carry huge fines when proven.
Judge McMahon on the Case
After the trial, Judge McMahon wrote that this was “a very big fraud on the government” that lasted almost a decade. She rejected arguments that the nearly $949 million fine was too high under the Constitution.
The judge’s comment showed she viewed the scheme as serious, noting Omnicare continued the billing practices even after CVS bought it.
Chapter 11 Bankruptcy Filed
On Sept. 22, 2025, Omnicare filed for Chapter 11 bankruptcy protection. The company said this would help resolve issues from the court ruling and other financial challenges.
It also said it planned to evaluate restructuring options, including a possible sale. This move paused any immediate payment of the nearly $1 billion judgment.
Keeping Business Running
Under bankruptcy protection, Omnicare said it will continue providing pharmacy services to nursing homes during the court process.
The company arranged $110 million in financing to keep operating. Omnicare expected this funding, with court approval, plus its normal business income, to cover costs such as employee wages and vendor payments.
Omnicare’s Official Statement
Omnicare’s president, David Azzolina, said the case was based on “technical violations of pharmacy law” that regulators had known about.
He noted there were “no allegations of harm to any Omnicare patients” and that people got the medicine they needed. Given this, he said the company would take “necessary steps to move forward” and continue providing care.
Commitments to Workers and Suppliers
Omnicare said it will pay employees and suppliers normally during bankruptcy. The company expects, with court approval, to keep wages and benefits on schedule and pay vendors in full for services and goods provided after the filing.
The goal is to support ongoing operations while it sorts out its debts.
Restructuring and Sale Plans
Omnicare said it plans to use the bankruptcy process to restructure or possibly sell parts of its business.
CVS Health said it will keep appealing the verdict. Industry analysts expect CVS may eventually sell Omnicare or reorganize the company once legal issues are resolved. The exact path forward remains uncertain.
Analysts’ Perspective
Analysts say Omnicare is a small part of CVS’s business. Rohan Kulkarni of HFS Research estimated Omnicare makes up only 3–4% of CVS’s total revenue.
After the verdict, CVS’s stock fell less than 1%; after the bankruptcy filing, the stock rose about 1%. Kulkarni said the debt and bankruptcy would not significantly hurt CVS’s overall finances.
Pharmacy Industry Trends
Omnicare’s case came at a tough time for pharmacies. In 2023, major chains like Rite Aid filed for bankruptcy, and Walgreens was sold to private equity.
Retail pharmacies faced stiff competition from online sellers like Amazon and shifting consumer habits. These shifts reflect broader industry problems that form the background to Omnicare’s case.
Reorganization and Appeals
Omnicare said it will continue servicing long-term care facilities during bankruptcy. In its court filings, Omnicare listed $1–$10 billion in liabilities and only $100–$500 million in assets.
CVS’s appeal of the fraud verdict is paused until the bankruptcy is finished. Omnicare is reorganizing under court supervision while the appeals court waits.
Current Status
Omnicare said it “remains fully focused on meeting the pharmacy needs of its customers”.
The company will keep filling prescriptions to nursing homes during bankruptcy. In its court filings, Omnicare listed $1–$10 billion in debts and only $100–$500 million in assets. The CVS appeal is paused until the bankruptcy is resolved.
The Human Toll
Inside nursing homes across the country, staff scrambled to find new suppliers as Omnicare’s bankruptcy spread uncertainty. Pharmacists worried about patient care, fearing delayed refills and missed doses. “We’re just trying to keep our residents safe,” one nurse told Reuters.
For thousands of elderly patients, the collapse wasn’t financial—it was deeply personal.
What Happens Next
As of 2025, Omnicare remains in Chapter 11 bankruptcy, continuing to serve its customers while awaiting court decisions. The nearly $1 billion fraud judgment is still unresolved, pending the outcome of appeals and the company’s reorganization plan.
That is the end of this story: Omnicare’s future depends on how the courts decide to handle its debts.